leukaemia
People whose work centres on leukaemia. 17 records carry it: 17 people.
Related tags
17 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Adrian Ochsenbein Director UCI; Chief Physician, Medical Oncology · Inselspital, Bern University Hospital / University Cancer Center Inselspital Bern medical oncology chief whose lab targets leukaemia stem cells and CD70 signalling. | Acute myeloid leukaemia, Chronic myeloid leukaemia | none | leadership, clinician-scientist, immunotherapy | ||
Antonio Cuneo President of the Scientific Committee · GIMEMA Ferrara haematologist and CLL expert who chairs GIMEMA's Scientific Committee. | Chronic lymphocytic leukaemia | none | leadership, clinician-scientist | ||
Brian Huntly President Elect · European Hematology Association Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted. | Acute myeloid leukaemia | none | leadership, clinician-scientist, haematology | ||
Francesco Lo-Coco Haematologist, University of Rome Tor Vergata (died 2019) Italian haematologist who led APL0406, the trial that showed acute promyelocytic leukaemia can be cured with all-trans retinoic acid and arsenic trioxide alone, without chemotherapy. | Acute promyelocytic leukaemia, Acute myeloid leukaemia | none | trialist | ||
Hervé Dombret Haematologist, Hôpital Saint-Louis (AP-HP), Paris · Cancer Institute AP-HP Nord, Université Paris Cité Paris haematologist who led AZA-AML-001, the trial that showed azacitidine can extend survival for older people with acute myeloid leukaemia who cannot have intensive chemotherapy. | Acute myeloid leukaemia in older or unfit patients, Acute myeloid leukaemia | none | trialist | ||
Hubert Serve Director, Department of Internal Medicine 2 (Hematology/Oncology) · University Cancer Center Frankfurt (UCT) Leukaemia specialist heading haematology and oncology at University Hospital Frankfurt and co-author of the pivotal RATIFY midostaurin trial. | Acute myeloid leukaemia | none | leadership, clinician-scientist, haematology | ||
Inge M. van der Sluis Paediatric oncologist, Princess Máxima Center for Pediatric Oncology · Princess Máxima Center for Pediatric Oncology Dutch paediatric oncologist who led the study showing that adding one course of blinatumomab to chemotherapy sharply improves survival for babies with KMT2A-rearranged leukaemia. | Infant acute lymphoblastic leukaemia, Acute lymphoblastic leukaemia, Childhood cancers | none | paediatric, immunotherapy, trialist | ||
Jan A. Burger Haematologist, MD Anderson Cancer Center · MD Anderson Cancer Center Leukaemia specialist who was lead author of RESONATE-2, the trial that made ibrutinib a first-line treatment for chronic lymphocytic leukaemia in older patients. | Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia | none | targeted-therapy, trialist | ||
Jeffrey E. Lancet Haematologist, Moffitt Cancer Center · Moffitt Cancer Center Florida leukaemia doctor who led the phase 3 trial of CPX-351, the liposomal form of daunorubicin and cytarabine that lengthened survival for older people with secondary acute myeloid leukaemia. | Secondary and therapy-related acute myeloid leukaemia, Acute myeloid leukaemia | none | trialist | ||
Kimberly P. Dunsmore Paediatric oncologist and Children's Oncology Group trial chair · Carilion Clinic / Virginia Tech Carilion School of Medicine Paediatric oncologist who chaired COG AALL0434, the largest trial ever run in childhood T-cell leukaemia, which showed that adding nelarabine improves disease-free survival. | High-risk acute lymphoblastic leukaemia in children, Acute lymphoblastic leukaemia, Childhood cancers | none | paediatric, trialist | ||
Konstanze Döhner President · European Hematology Association Ulm haematologist and President of the European Hematology Association, a leading figure in the molecular genetics and risk classification of acute myeloid leukaemia. | Acute myeloid leukaemia | none | leadership, clinician-scientist, haematology | ||
Marco Vignetti President · GIMEMA Haematologist who presides over GIMEMA, Italy's adult haematological malignancies cooperative group, and co-authored its chemotherapy-free Ph+ ALL trial. | Acute lymphoblastic leukaemia, Acute myeloid leukaemia | none | leadership, clinician-scientist, clinical trials | ||
Martin Bornhäuser Managing Director (Geschäftsführender Direktor); Director, Medizinische Klinik und Poliklinik I · NCT/UCC Dresden, University Hospital Carl Gustav Carus Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials. | Acute myeloid leukaemia, Multiple myeloma | none | leadership, clinician-scientist, haematology | ||
Miguel A. Sanz Haematologist, Hospital Universitari i Politècnic La Fe, Valencia · Hospital Universitari i Politècnic La Fe Spanish haematologist who led the PETHEMA trials that tailored acute promyelocytic leukaemia treatment to relapse risk, and who chaired the European LeukemiaNet recommendations for the disease. | Acute promyelocytic leukaemia, Acute myeloid leukaemia | none | guidelines | ||
Rob Pieters Paediatric oncologist and Chief Medical Officer, Princess Máxima Center for Pediatric Oncology · Princess Máxima Center for Pediatric Oncology Dutch paediatric oncologist who led the international Interfant trials for babies with leukaemia and helped create the Princess Máxima Center, which brought all Dutch childhood cancer care into one hospital. | Infant acute lymphoblastic leukaemia, Acute lymphoblastic leukaemia, Childhood cancers | none | paediatric, trialist | ||
Thomas Kindler Director · University Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz Haematologist-oncologist who directs the University Cancer Center Mainz at Universitätsmedizin Mainz. | Acute myeloid leukaemia | none | leadership, clinician-scientist, haematology | ||
Tim Somervaille Senior Group Leader · Cancer Research UK Manchester Institute Haematologist and Senior Group Leader at CRUK Manchester Institute studying the transcriptional drivers of acute myeloid leukaemia. | Acute myeloid leukaemia | none | clinician-scientist, haematology |